Clinical Trial Update: Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4） [Phase 3]

View source ↗

Summary

A Phase 3 trial (CHANCE-4) is evaluating tirofiban for patients with symptomatic intracranial arterial stenosis and high-risk acute non-disabling cerebrovascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerotic Stenosis
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute, TIA | Phase 3 | Status: RECRUITING